Report Detail
Global SPECT Radiopharmaceuticals Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
- RnM3728114 |
- 12 June, 2024 |
- Global |
- 93 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global SPECT Radiopharmaceuticals market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.
A Single Photon Emission Computed Tomography (SPECT) scan is a type of nuclear imaging test that shows how blood flows to tissues and organs. Nuclear imaging requires small amounts of radioactive materials called radiopharmaceuticals – injected, inhaled or swallowed – to diagnose disease. SPECT radiopharmaceuticals include Tc-99m, Tl-201, Ga-67, I-123, In-111，and other SPECT isotopes.
The Global Info Research report includes an overview of the development of the SPECT Radiopharmaceuticals industry chain, the market status of Oncology (Technetium-99, Thallium-201), Cardiology (Technetium-99, Thallium-201), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of SPECT Radiopharmaceuticals.
Regionally, the report analyzes the SPECT Radiopharmaceuticals markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global SPECT Radiopharmaceuticals market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the SPECT Radiopharmaceuticals market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the SPECT Radiopharmaceuticals industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Technetium-99, Thallium-201).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the SPECT Radiopharmaceuticals market.
Regional Analysis: The report involves examining the SPECT Radiopharmaceuticals market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the SPECT Radiopharmaceuticals market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to SPECT Radiopharmaceuticals:
Company Analysis: Report covers individual SPECT Radiopharmaceuticals manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards SPECT Radiopharmaceuticals This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Oncology, Cardiology).
Technology Analysis: Report covers specific technologies relevant to SPECT Radiopharmaceuticals. It assesses the current state, advancements, and potential future developments in SPECT Radiopharmaceuticals areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the SPECT Radiopharmaceuticals market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
SPECT Radiopharmaceuticals market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Technetium-99
Thallium-201
Gallium-67
Iodine-123
Indium-111
Other
Market segment by Application
Oncology
Cardiology
Thyroid
Major players covered
GE Healthcare
Cardinal Health
Lantheus Medical Imaging
Bracco Imaging
Eczacibasi-Monrol Nuclear Products
IBA Molecular Imaging
Jubilant Life Sciences
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe SPECT Radiopharmaceuticals product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of SPECT Radiopharmaceuticals, with price, sales, revenue and global market share of SPECT Radiopharmaceuticals from 2019 to 2024.
Chapter 3, the SPECT Radiopharmaceuticals competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the SPECT Radiopharmaceuticals breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and SPECT Radiopharmaceuticals market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of SPECT Radiopharmaceuticals.
Chapter 14 and 15, to describe SPECT Radiopharmaceuticals sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of SPECT Radiopharmaceuticals
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global SPECT Radiopharmaceuticals Consumption Value by Type: 2019 Versus 2023 Versus 2030
- 1.3.2 Technetium-99
- 1.3.3 Thallium-201
- 1.3.4 Gallium-67
- 1.3.5 Iodine-123
- 1.3.6 Indium-111
- 1.3.7 Other
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global SPECT Radiopharmaceuticals Consumption Value by Application: 2019 Versus 2023 Versus 2030
- 1.4.2 Oncology
- 1.4.3 Cardiology
- 1.4.4 Thyroid
- 1.5 Global SPECT Radiopharmaceuticals Market Size & Forecast
- 1.5.1 Global SPECT Radiopharmaceuticals Consumption Value (2019 & 2023 & 2030)
- 1.5.2 Global SPECT Radiopharmaceuticals Sales Quantity (2019-2030)
- 1.5.3 Global SPECT Radiopharmaceuticals Average Price (2019-2030)
2 Manufacturers Profiles
- 2.1 GE Healthcare
- 2.1.1 GE Healthcare Details
- 2.1.2 GE Healthcare Major Business
- 2.1.3 GE Healthcare SPECT Radiopharmaceuticals Product and Services
- 2.1.4 GE Healthcare SPECT Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.1.5 GE Healthcare Recent Developments/Updates
- 2.2 Cardinal Health
- 2.2.1 Cardinal Health Details
- 2.2.2 Cardinal Health Major Business
- 2.2.3 Cardinal Health SPECT Radiopharmaceuticals Product and Services
- 2.2.4 Cardinal Health SPECT Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.2.5 Cardinal Health Recent Developments/Updates
- 2.3 Lantheus Medical Imaging
- 2.3.1 Lantheus Medical Imaging Details
- 2.3.2 Lantheus Medical Imaging Major Business
- 2.3.3 Lantheus Medical Imaging SPECT Radiopharmaceuticals Product and Services
- 2.3.4 Lantheus Medical Imaging SPECT Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.3.5 Lantheus Medical Imaging Recent Developments/Updates
- 2.4 Bracco Imaging
- 2.4.1 Bracco Imaging Details
- 2.4.2 Bracco Imaging Major Business
- 2.4.3 Bracco Imaging SPECT Radiopharmaceuticals Product and Services
- 2.4.4 Bracco Imaging SPECT Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.4.5 Bracco Imaging Recent Developments/Updates
- 2.5 Eczacibasi-Monrol Nuclear Products
- 2.5.1 Eczacibasi-Monrol Nuclear Products Details
- 2.5.2 Eczacibasi-Monrol Nuclear Products Major Business
- 2.5.3 Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Product and Services
- 2.5.4 Eczacibasi-Monrol Nuclear Products SPECT Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.5.5 Eczacibasi-Monrol Nuclear Products Recent Developments/Updates
- 2.6 IBA Molecular Imaging
- 2.6.1 IBA Molecular Imaging Details
- 2.6.2 IBA Molecular Imaging Major Business
- 2.6.3 IBA Molecular Imaging SPECT Radiopharmaceuticals Product and Services
- 2.6.4 IBA Molecular Imaging SPECT Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.6.5 IBA Molecular Imaging Recent Developments/Updates
- 2.7 Jubilant Life Sciences
- 2.7.1 Jubilant Life Sciences Details
- 2.7.2 Jubilant Life Sciences Major Business
- 2.7.3 Jubilant Life Sciences SPECT Radiopharmaceuticals Product and Services
- 2.7.4 Jubilant Life Sciences SPECT Radiopharmaceuticals Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
- 2.7.5 Jubilant Life Sciences Recent Developments/Updates
3 Competitive Environment: SPECT Radiopharmaceuticals by Manufacturer
- 3.1 Global SPECT Radiopharmaceuticals Sales Quantity by Manufacturer (2019-2024)
- 3.2 Global SPECT Radiopharmaceuticals Revenue by Manufacturer (2019-2024)
- 3.3 Global SPECT Radiopharmaceuticals Average Price by Manufacturer (2019-2024)
- 3.4 Market Share Analysis (2023)
- 3.4.1 Producer Shipments of SPECT Radiopharmaceuticals by Manufacturer Revenue ($MM) and Market Share (%): 2023
- 3.4.2 Top 3 SPECT Radiopharmaceuticals Manufacturer Market Share in 2023
- 3.4.2 Top 6 SPECT Radiopharmaceuticals Manufacturer Market Share in 2023
- 3.5 SPECT Radiopharmaceuticals Market: Overall Company Footprint Analysis
- 3.5.1 SPECT Radiopharmaceuticals Market: Region Footprint
- 3.5.2 SPECT Radiopharmaceuticals Market: Company Product Type Footprint
- 3.5.3 SPECT Radiopharmaceuticals Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global SPECT Radiopharmaceuticals Market Size by Region
- 4.1.1 Global SPECT Radiopharmaceuticals Sales Quantity by Region (2019-2030)
- 4.1.2 Global SPECT Radiopharmaceuticals Consumption Value by Region (2019-2030)
- 4.1.3 Global SPECT Radiopharmaceuticals Average Price by Region (2019-2030)
- 4.2 North America SPECT Radiopharmaceuticals Consumption Value (2019-2030)
- 4.3 Europe SPECT Radiopharmaceuticals Consumption Value (2019-2030)
- 4.4 Asia-Pacific SPECT Radiopharmaceuticals Consumption Value (2019-2030)
- 4.5 South America SPECT Radiopharmaceuticals Consumption Value (2019-2030)
- 4.6 Middle East and Africa SPECT Radiopharmaceuticals Consumption Value (2019-2030)
5 Market Segment by Type
- 5.1 Global SPECT Radiopharmaceuticals Sales Quantity by Type (2019-2030)
- 5.2 Global SPECT Radiopharmaceuticals Consumption Value by Type (2019-2030)
- 5.3 Global SPECT Radiopharmaceuticals Average Price by Type (2019-2030)
6 Market Segment by Application
- 6.1 Global SPECT Radiopharmaceuticals Sales Quantity by Application (2019-2030)
- 6.2 Global SPECT Radiopharmaceuticals Consumption Value by Application (2019-2030)
- 6.3 Global SPECT Radiopharmaceuticals Average Price by Application (2019-2030)
7 North America
- 7.1 North America SPECT Radiopharmaceuticals Sales Quantity by Type (2019-2030)
- 7.2 North America SPECT Radiopharmaceuticals Sales Quantity by Application (2019-2030)
- 7.3 North America SPECT Radiopharmaceuticals Market Size by Country
- 7.3.1 North America SPECT Radiopharmaceuticals Sales Quantity by Country (2019-2030)
- 7.3.2 North America SPECT Radiopharmaceuticals Consumption Value by Country (2019-2030)
- 7.3.3 United States Market Size and Forecast (2019-2030)
- 7.3.4 Canada Market Size and Forecast (2019-2030)
- 7.3.5 Mexico Market Size and Forecast (2019-2030)
8 Europe
- 8.1 Europe SPECT Radiopharmaceuticals Sales Quantity by Type (2019-2030)
- 8.2 Europe SPECT Radiopharmaceuticals Sales Quantity by Application (2019-2030)
- 8.3 Europe SPECT Radiopharmaceuticals Market Size by Country
- 8.3.1 Europe SPECT Radiopharmaceuticals Sales Quantity by Country (2019-2030)
- 8.3.2 Europe SPECT Radiopharmaceuticals Consumption Value by Country (2019-2030)
- 8.3.3 Germany Market Size and Forecast (2019-2030)
- 8.3.4 France Market Size and Forecast (2019-2030)
- 8.3.5 United Kingdom Market Size and Forecast (2019-2030)
- 8.3.6 Russia Market Size and Forecast (2019-2030)
- 8.3.7 Italy Market Size and Forecast (2019-2030)
9 Asia-Pacific
- 9.1 Asia-Pacific SPECT Radiopharmaceuticals Sales Quantity by Type (2019-2030)
- 9.2 Asia-Pacific SPECT Radiopharmaceuticals Sales Quantity by Application (2019-2030)
- 9.3 Asia-Pacific SPECT Radiopharmaceuticals Market Size by Region
- 9.3.1 Asia-Pacific SPECT Radiopharmaceuticals Sales Quantity by Region (2019-2030)
- 9.3.2 Asia-Pacific SPECT Radiopharmaceuticals Consumption Value by Region (2019-2030)
- 9.3.3 China Market Size and Forecast (2019-2030)
- 9.3.4 Japan Market Size and Forecast (2019-2030)
- 9.3.5 Korea Market Size and Forecast (2019-2030)
- 9.3.6 India Market Size and Forecast (2019-2030)
- 9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
- 9.3.8 Australia Market Size and Forecast (2019-2030)
10 South America
- 10.1 South America SPECT Radiopharmaceuticals Sales Quantity by Type (2019-2030)
- 10.2 South America SPECT Radiopharmaceuticals Sales Quantity by Application (2019-2030)
- 10.3 South America SPECT Radiopharmaceuticals Market Size by Country
- 10.3.1 South America SPECT Radiopharmaceuticals Sales Quantity by Country (2019-2030)
- 10.3.2 South America SPECT Radiopharmaceuticals Consumption Value by Country (2019-2030)
- 10.3.3 Brazil Market Size and Forecast (2019-2030)
- 10.3.4 Argentina Market Size and Forecast (2019-2030)
11 Middle East & Africa
- 11.1 Middle East & Africa SPECT Radiopharmaceuticals Sales Quantity by Type (2019-2030)
- 11.2 Middle East & Africa SPECT Radiopharmaceuticals Sales Quantity by Application (2019-2030)
- 11.3 Middle East & Africa SPECT Radiopharmaceuticals Market Size by Country
- 11.3.1 Middle East & Africa SPECT Radiopharmaceuticals Sales Quantity by Country (2019-2030)
- 11.3.2 Middle East & Africa SPECT Radiopharmaceuticals Consumption Value by Country (2019-2030)
- 11.3.3 Turkey Market Size and Forecast (2019-2030)
- 11.3.4 Egypt Market Size and Forecast (2019-2030)
- 11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
- 11.3.6 South Africa Market Size and Forecast (2019-2030)
12 Market Dynamics
- 12.1 SPECT Radiopharmaceuticals Market Drivers
- 12.2 SPECT Radiopharmaceuticals Market Restraints
- 12.3 SPECT Radiopharmaceuticals Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of SPECT Radiopharmaceuticals and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of SPECT Radiopharmaceuticals
- 13.3 SPECT Radiopharmaceuticals Production Process
- 13.4 SPECT Radiopharmaceuticals Industrial Chain
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 SPECT Radiopharmaceuticals Typical Distributors
- 14.3 SPECT Radiopharmaceuticals Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on SPECT Radiopharmaceuticals. Industry analysis & Market Report on SPECT Radiopharmaceuticals is a syndicated market report, published as Global SPECT Radiopharmaceuticals Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030. It is complete Research Study and Industry Analysis of SPECT Radiopharmaceuticals market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
